Cargando…

Prospective changes of cardiac iron and function in low and intermediate-1 risk mds patients

Detalles Bibliográficos
Autores principales:	Pepe, Alessia, Meloni, Antonella, Carulli, Giovanni, Oliva, Esther N, Arcioni, Francesco, Storti, Sergio, Neri, Mari Giovanna, Grassedonio, Emanuele, Renne, Stefania, Restaino, Gennaro, Positano, Vincenzo, Rizzo, Michele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4328565/ http://dx.doi.org/10.1186/1532-429X-17-S1-P376

Ejemplares similares

Prospective changes of cardiac iron and function by MR in pediatric thalassemia major patients treated with different chelators or not chelated
por: Meloni, Antonella, et al.
Publicado: (2015)

Changes of cardiac iron and function during pregnancy in trasfusion-dependent thalassemia patients
por: Meloni, Antonella, et al.
Publicado: (2016)

Association between serum ferritin and liver iron concentration with cardiac iron in pediatric thalassemia major patients
por: Meloni, Antonella, et al.
Publicado: (2016)

Left ventricular global function index and left ventricular mass volume ratio by CMR: relation with heart failure in Thalassemia major patients
por: Meloni, Antonella, et al.
Publicado: (2015)

Pancreatic fatty replacement as risk marker for altered glucose metabolism and cardiac iron and complications in thalassemia major
por: Meloni, Antonella, et al.
Publicado: (2023)

Different patterns of myocardial iron overload by multislice T2* Cardiovascular MR as markers of risk for cardiac dysfunction in thalassemia major
por: Meloni, Antonella, et al.
Publicado: (2011)

A prospective MRI study of left ventricular iron and function in non-trasfusion-dependent thalassemia intermedia patients treated with desferrioxamine
por: Meloni, Antonella, et al.
Publicado: (2015)

Reference ranges for biventricular volumes and ejection fraction and for left ventricular mass in adult thalassemia intermedia patients without myocardial iron overload
por: Meloni, Antonella, et al.
Publicado: (2013)

MRI prospective survey on cardiac and hepatic iron in transfusion-dependent thalassemia intermedia patients treated with desferrioxamine, deferiprone and deferasirox
por: Meloni, Antonella, et al.
Publicado: (2015)

Regional myocardial contractility in Thalassemia Major by magnetic resonance tagging
por: Meloni, Antonella, et al.
Publicado: (2014)

Right ventricular wall motion abnormalities n Thalassemia Major patients
por: Meloni, Antonella, et al.
Publicado: (2014)

CMR T2* technique for segmental and global quantification of myocardial iron: multi-centre transfereability and healtcare impact evalaution
por: Positano, Vincenzo, et al.
Publicado: (2009)

Diabetes mellitus and cardiac complications in thalassemia major patients
por: Pepe, Alessia, et al.
Publicado: (2012)

Phenotypic Clustering of Beta-Thalassemia Intermedia Patients Using Cardiovascular Magnetic Resonance
por: Meloni, Antonella, et al.
Publicado: (2023)

The Link of Pancreatic Iron with Glucose Metabolism and Cardiac Iron in Thalassemia Intermedia: A Large, Multicenter Observational Study
por: Meloni, Antonella, et al.
Publicado: (2021)

Left Ventricular Volumes, Mass and Function normalized to the body surface area, age and gender from CMR in a large cohort of well-treated Thalassemia Major patients without myocardial iron overload
por: Meloni, Antonella, et al.
Publicado: (2011)

Right Ventricular Volumes and Function normalized to body surface area, age and sex in a large cohort of well-treated Thalassemia Major without myocardial iron overload
por: Meloni, Antonella, et al.
Publicado: (2011)

Are the preferential patterns of myocardial iron overload preserved at the CMR follow-up?
por: Meloni, Antonella, et al.
Publicado: (2012)

Myocardial iron overload in thalassemia major. How early to check?
por: Meloni, Antonella, et al.
Publicado: (2014)

Different patterns of myocardial iron overload by T2* Cardiovascular MR as markers of risk for cardiac complication in thalassemia major
por: Meloni, Antonella, et al.
Publicado: (2012)

Myocardial iron overload in sickle/thalassemia patients of Italian origin
por: Meloni, Antonella, et al.
Publicado: (2013)

Impact of the COVID-19 Pandemic on Iron Overload Assessment by MRI in Patients with Hemoglobinopathies: The E-MIOT Network Experience
por: Meloni, Antonella, et al.
Publicado: (2023)

The impact of iron chelation therapy on patients with lower/intermediate IPSS MDS and the prognostic role of elevated serum ferritin in patients with MDS and AML: A meta-analysis
por: Yang, Yuan, et al.
Publicado: (2019)

P1459: CHRONIC HEPATITIS C VIRUS INFECTION IS ASSOCIATED WITH AN INCREASED RISK OF CARDIAC COMPLICATIONS IN THALASSEMIA MAJOR
por: Meloni, Antonella, et al.
Publicado: (2023)

A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferipron-desferrioxamine versus deferasirox
por: Pepe, Alessia, et al.
Publicado: (2011)

An automatic method for myocardial T2* curve fitting in thalassemia patients with severe iron overload
por: Meloni, Antonella, et al.
Publicado: (2013)

T2* heterogeneity detected by CMR could be related to myocardial iron distribution in Thalassemia patients
por: Positano, Vincenzo, et al.
Publicado: (2009)

Prospective changes of pancreatic iron in patients with thalassemia major and association with chelation therapy
por: Meloni, Antonella, et al.
Publicado: (2022)

Link between Genotype and Multi-Organ Iron and Complications in Children with Transfusion-Dependent Thalassemia
por: Meloni, Antonella, et al.
Publicado: (2022)

Controversies on the Consequences of Iron Overload and Chelation in MDS
por: Vinchi, Francesca, et al.
Publicado: (2020)

Significant improvement of survival by T2* CMR in thalassemia major
por: Meloni, Antonella, et al.
Publicado: (2016)

A T2* MRI prospective survey on heart iron in thalassemia major patients treated with sequential deferiprone-desferrioxamine versus deferipron and desferrioxamine in monotherapy
por: Pepe, Alessia, et al.
Publicado: (2011)

Iron overload in myelodysplastic syndromes (MDS) – diagnosis, management, and response criteria: a proposal of the Austrian MDS platform
por: Valent, P, et al.
Publicado: (2008)

Multi-Parametric Cardiac Magnetic Resonance for Prediction of Heart Failure Death in Thalassemia Major
por: Meloni, Antonella, et al.
Publicado: (2023)

P1457: MOTION ABNORMALITIES IN THE LEFT VENTRICLE OF THALASSEMIA INTERMEDIA PATIENTS
por: Meloni, Antonella, et al.
Publicado: (2023)

CMR survey in Thalassemia Intermedia patients
por: Meloni, Antonella, et al.
Publicado: (2014)

Heart T2* for prediction of cardiac complications in well-treated thalassemia major patients
por: Pepe, Alessia, et al.
Publicado: (2012)

Should every Patient with MDS get Iron Chelation – Probably Yes
por: Ghosh, Kanjaksha, et al.
Publicado: (2017)

Proliferative activity is disturbed in myeloproliferative neoplasms (MPN), myelodysplastic syndrome (MDS), and MDS/MPN diseases. Differences between MDS and MDS/MPN
por: Mestrum, Stefan G. C., et al.
Publicado: (2020)

Myocardial iron overload by cardiovascular magnetic resonance native segmental T1 mapping: a sensitive approach that correlates with cardiac complications
por: Meloni, Antonella, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lu1eublalt4fqj5jlclfbi3vcu